198 related articles for article (PubMed ID: 37832631)
1. CRISPR-based precision medicine for hematologic disorders: Advancements, challenges, and prospects.
Sahu S; Poplawska M; Lim SH; Dutta D
Life Sci; 2023 Nov; 333():122165. PubMed ID: 37832631
[TBL] [Abstract][Full Text] [Related]
2. Gene editing and its application for hematological diseases.
Osborn MJ; Belanto JJ; Tolar J; Voytas DF
Int J Hematol; 2016 Jul; 104(1):18-28. PubMed ID: 27233509
[TBL] [Abstract][Full Text] [Related]
3. Applications of Alternative Nucleases in the Age of CRISPR/Cas9.
Guha TK; Edgell DR
Int J Mol Sci; 2017 Nov; 18(12):. PubMed ID: 29186020
[TBL] [Abstract][Full Text] [Related]
4. Application of genome editing technologies to the study and treatment of hematological disease.
Pellagatti A; Dolatshad H; Yip BH; Valletta S; Boultwood J
Adv Biol Regul; 2016 Jan; 60():122-134. PubMed ID: 26433620
[TBL] [Abstract][Full Text] [Related]
5. Enabling Precision Medicine with CRISPR-Cas Genome Editing Technology: A Translational Perspective.
Ilahibaks NF; Hulsbos MJ; Lei Z; Vader P; Sluijter JPG
Adv Exp Med Biol; 2023; 1396():315-339. PubMed ID: 36454475
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas systems: Challenges and future prospects.
Gohil N; Bhattacharjee G; Lam NL; Perli SD; Singh V
Prog Mol Biol Transl Sci; 2021; 180():141-151. PubMed ID: 33934835
[TBL] [Abstract][Full Text] [Related]
7. The application of the CRISPR-Cas9 genome editing machinery in food and agricultural science: Current status, future perspectives, and associated challenges.
Eş I; Gavahian M; Marti-Quijal FJ; Lorenzo JM; Mousavi Khaneghah A; Tsatsanis C; Kampranis SC; Barba FJ
Biotechnol Adv; 2019; 37(3):410-421. PubMed ID: 30779952
[TBL] [Abstract][Full Text] [Related]
8. Non-viral delivery of genome-editing nucleases for gene therapy.
Wang M; Glass ZA; Xu Q
Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
[TBL] [Abstract][Full Text] [Related]
9. Basics of genome editing technology and its application in livestock species.
Petersen B
Reprod Domest Anim; 2017 Aug; 52 Suppl 3():4-13. PubMed ID: 28815851
[TBL] [Abstract][Full Text] [Related]
10. Construction and Evaluation of Zinc Finger Nucleases.
Ochiai H; Yamamoto T
Methods Mol Biol; 2023; 2637():1-25. PubMed ID: 36773134
[TBL] [Abstract][Full Text] [Related]
11. CRISPR to fix bad blood: a new tool in basic and clinical hematology.
González-Romero E; Martínez-Valiente C; García-Ruiz C; Vázquez-Manrique RP; Cervera J; Sanjuan-Pla A
Haematologica; 2019 May; 104(5):881-893. PubMed ID: 30923099
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9 Technology for the Creation of Biological Avatars Capable of Modeling and Treating Pathologies: From Discovery to the Latest Improvements.
Nasrallah A; Sulpice E; Kobaisi F; Gidrol X; Rachidi W
Cells; 2022 Nov; 11(22):. PubMed ID: 36429042
[TBL] [Abstract][Full Text] [Related]
13. Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9.
Zhang HX; Zhang Y; Yin H
Mol Ther; 2019 Apr; 27(4):735-746. PubMed ID: 30803822
[TBL] [Abstract][Full Text] [Related]
14. Tools for Efficient Genome Editing; ZFN, TALEN, and CRISPR.
Shamshirgaran Y; Liu J; Sumer H; Verma PJ; Taheri-Ghahfarokhi A
Methods Mol Biol; 2022; 2495():29-46. PubMed ID: 35696026
[TBL] [Abstract][Full Text] [Related]
15. Editing the genome of common cereals (Rice and Wheat): techniques, applications, and industrial aspects.
Das N; Ghosh Dhar D; Dhar P
Mol Biol Rep; 2023 Jan; 50(1):739-747. PubMed ID: 36309609
[TBL] [Abstract][Full Text] [Related]
16. Genome centric engineering using ZFNs, TALENs and CRISPR-Cas9 systems for trait improvement and disease control in Animals.
Wani AK; Akhtar N; Singh R; Prakash A; Raza SHA; Cavalu S; Chopra C; Madkour M; Elolimy A; Hashem NM
Vet Res Commun; 2023 Jan; 47(1):1-16. PubMed ID: 35781172
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
18. Genome editing comes of age.
Kim JS
Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic gene editing in haematological disorders with CRISPR/Cas9.
Jensen TI; Axelgaard E; Bak RO
Br J Haematol; 2019 Jun; 185(5):821-835. PubMed ID: 30864164
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
